Olix Plunges 14% and Lockit Healthcare Hits 52-Week Low as Clinical Trial Application Rejected [Bio Market Briefing]
Predicted impact: Medium· Actual: −10.0% vs sector, volume 0.6× normal (5 trading days)
Clinical trial application rejection at a different company; Rokit impact unclear, only a 52-week low noted.